US Patent 12005061 Ophthalmic formulations of methotrexate
Patent 12005061 was granted and assigned to Aldeyra Therapeutics on June, 2024 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 15, 2022
0
Date of Patent
June 11, 2024
0
Patent Applicant
Patent Application Number
17932453
0
Patent Inventor Names
Tomasz Stryjewski
0
Stephen Gitu Machatha
0
Dean Eliott
0
Pramod Sarpotdar
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
CPC Code
Find more entities like US Patent 12005061 Ophthalmic formulations of methotrexate
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
